Personalized medicine of type 2 diabetes

被引：6
|
作者：
Jia, Weiping [1 ,2 ,3 ,4 ]
机构：
[1] Shanghai Diabet Inst, Shanghai 200233, Peoples R China
[2] Shanghai Jiao Tong Univ, Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai 200233, Peoples R China
[3] Shanghai Key Lab Diabet Mellitus, Shanghai 200233, Peoples R China
[4] Shanghai Clin Ctr Diabet, Shanghai 200233, Peoples R China
来源：
FRONTIERS OF MEDICINE | 2013年 / 7卷 / 01期
关键词：
D O I：
10.1007/s11684-013-0241-y
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1 / 3
页数：3
相关论文
共 50 条
  • [31] Lifestyle Medicine in Type 2 Diabetes
    Rejeski, W. J.
    Ip, E. H.
    Bertoni, A. G.
    Bray, G. A.
    Evans, G.
    Gregg, E. W.
    Zhang, Q.
    FORSCHENDE KOMPLEMENTARMEDIZIN, 2012, 19 (03): : 160 - 162
  • [32] Precision Medicine for Type 2 Diabetes
    Villagran, Marcelo
    Martorell, Miquel
    Diaz, Fredy
    Petermann-Rocha, Fanny
    Celis-Morales, Carlos
    REVISTA MEDICA DE CHILE, 2022, 150 (02) : 273 - 275
  • [33] Precision medicine in type 2 diabetes
    Prasad, R. B.
    Groop, L.
    JOURNAL OF INTERNAL MEDICINE, 2019, 285 (01) : 40 - 48
  • [34] The role of metabolomics in personalized medicine for diabetes
    Chowdhury, Shamiha
    Faheem, Sultan Mohammed
    Nawaz, Shaik Sarfaraz
    Siddiqui, Khalid
    PERSONALIZED MEDICINE, 2021, 18 (05) : 501 - 508
  • [35] Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
    Avery, Peter
    Mousa, Shaymaa S.
    Mousa, Shaker A.
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2009, 2 : 79 - 91
  • [36] Introduction to Personalized Medicine in Diabetes Mellitus
    Glauber, Harry S.
    Rishe, Naphtali
    Karnieli, Eddy
    RAMBAM MAIMONIDES MEDICAL JOURNAL, 2014, 5 (01):
  • [37] Pharmacogenetics and personalized treatment of type 2 diabetes mellitus
    Yang, Pablo
    Ojeda Heredia, Veronica
    Beltramo, Dante M.
    Soria, Nestor W.
    INTERNATIONAL JOURNAL OF DIABETES IN DEVELOPING COUNTRIES, 2016, 36 (04) : 508 - 518
  • [38] Pharmacogenetics and personalized treatment of type 2 diabetes mellitus
    Pablo Yang
    Verónica Ojeda Heredia
    Dante M. Beltramo
    Néstor W. Soria
    International Journal of Diabetes in Developing Countries, 2016, 36 : 508 - 518
  • [39] Feasibility of digital phenotyping based on continuous glucose monitoring to support personalized lifestyle medicine in type 2 diabetes
    van den Brink, Willem J.
    van den Broek, Tim J.
    Wopereis, Suzan
    Difrancesco, Sonia
    van der Horst, Frans A. L.
    de Hoogh, Iris M.
    MATURITAS, 2025, 194
  • [40] 'Personalized Medicine' To Identify Genetic Risks For Type 2 Diabetes And Focus Prevention: Can It Fulfill Its Promise?
    Spiegel, Allen M.
    Hawkins, Meredith
    HEALTH AFFAIRS, 2012, 31 (01) : 43 - 49
12345